advantageaustria.org does not support this browser, some features and elements are not supported. Please use another browser such as Firefox, Chrome, Edge etc.
AFreeze has developed and obtained regulatory approval for a patented cryo-ablation catheter to treat atrial fibrillation (AF). AF affects 30 million people globally. The ablation of AF is an established therapy. The USD 4 bn market shows 10% growth rates p.a.
The CoolLoop® cryo-ablation system provides an ...
